These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 25023396)
1. Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy. Patel N; Souhami L; Mansure JJ; Duclos M; Aprikian A; Faria S; David M; Cury FL Brachytherapy; 2014; 13(5):450-5. PubMed ID: 25023396 [TBL] [Abstract][Full Text] [Related]
2. PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation. McGrath SD; Antonucci JV; Fitch DL; Ghilezan M; Gustafson GS; Vicini FA; Martinez AA; Kestin LL Brachytherapy; 2010; 9(2):137-44. PubMed ID: 19850537 [TBL] [Abstract][Full Text] [Related]
3. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Ciezki JP; Reddy CA; Garcia J; Angermeier K; Ulchaker J; Mahadevan A; Chehade N; Altman A; Klein EA Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):512-7. PubMed ID: 16213667 [TBL] [Abstract][Full Text] [Related]
4. Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation. Fitch DL; McGrath S; Martinez AA; Vicini FA; Kestin LL Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1430-9. PubMed ID: 16765527 [TBL] [Abstract][Full Text] [Related]
5. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer. Mitchell DM; Swindell R; Elliott T; Wylie JP; Taylor CM; Logue JP Radiother Oncol; 2008 Jul; 88(1):102-7. PubMed ID: 18453022 [TBL] [Abstract][Full Text] [Related]
6. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Crook J; Gillan C; Yeung I; Austen L; McLean M; Lockwood G Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):426-33. PubMed ID: 17869662 [TBL] [Abstract][Full Text] [Related]
7. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. Critz FA; Williams WH; Levinson AK; Benton JB; Schnell FJ; Holladay CT; Shrake PD J Urol; 2003 Nov; 170(5):1864-7. PubMed ID: 14532794 [TBL] [Abstract][Full Text] [Related]
8. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiation therapy in the treatment of intermediate-risk prostate cancer - long term results. Cury FL; Duclos M; Aprikian A; Patrocinio H; Kassouf W; Shenouda G; Faria S; David M; Souhami L Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1417-23. PubMed ID: 21784585 [TBL] [Abstract][Full Text] [Related]
9. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome. Bachand F; Martin AG; Beaulieu L; Harel F; Vigneault E Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):679-84. PubMed ID: 18963537 [TBL] [Abstract][Full Text] [Related]
10. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup. Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467 [TBL] [Abstract][Full Text] [Related]
11. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788 [TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis. Satoh T; Ishiyama H; Matsumoto K; Tsumura H; Kitano M; Hayakawa K; Ebara S; Nasu Y; Kumon H; Kanazawa S; Miki K; Egawa S; Aoki M; Toya K; Yorozu A; Nagata H; Saito S; Baba S BJU Int; 2009 Apr; 103(8):1064-8. PubMed ID: 19040526 [TBL] [Abstract][Full Text] [Related]
13. PSA nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. Ko EC; Stone NN; Stock RG Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):600-7. PubMed ID: 21985944 [TBL] [Abstract][Full Text] [Related]
14. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Akyol F; Ozyigit G; Selek U; Karabulut E Eur Urol; 2005 Jul; 48(1):40-5. PubMed ID: 15967250 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response. Jabbari S; Weinberg VK; Kaprealian T; Hsu IC; Ma L; Chuang C; Descovich M; Shiao S; Shinohara K; Roach M; Gottschalk AR Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):228-34. PubMed ID: 21183287 [TBL] [Abstract][Full Text] [Related]
16. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Chen CP; Weinberg V; Shinohara K; Roach M; Nash M; Gottschalk A; Chang AJ; Hsu IC Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):324-9. PubMed ID: 23474112 [TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer. Sheinbein C; Teh BS; Mai WY; Grant W; Paulino A; Butler EB Urology; 2010 Sep; 76(3):728-33. PubMed ID: 19616279 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer. Kotecha R; Yamada Y; Pei X; Kollmeier MA; Cox B; Cohen GN; Zaider M; Zelefsky MJ Brachytherapy; 2013; 12(1):44-9. PubMed ID: 22831750 [TBL] [Abstract][Full Text] [Related]
19. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation. Vicini FA; Kestin LL; Martinez AA Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815 [TBL] [Abstract][Full Text] [Related]
20. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]